Literature DB >> 34787798

Oxidative stress and macrophage infiltration in IgA nephropathy.

Yasar Caliskan1,2, Erol Demir3, Ecem Karatay4, Yasemin Ozluk4, Safak Mirioglu3,5, Ahmet Burak Dirim3, Ayse Serra Artan3, Sebahat Usta Akgul6, Ozgur Akin Oto3, Fatma Savran Oguz6, Aydin Turkmen3, Krista L Lentine7, Halil Yazici3.   

Abstract

BACKGROUND: The aim of this study was to evaluate the interactions among serum levels of galactose-deficient IgA1 (Gd-IgA1), oxidative stress and macrophage infiltration and their clinical correlates in patients with IgA Nephropathy (IgAN).
METHODS: A total of 47 patients with biopsy-proven primary IgAN, aged between 16 and 79 years, with a follow-up period ≥ 1 year or who showed progression to end stage kidney disease (ESKD) regardless the duration of follow-up were included. Study endpoint was the progression to ESKD. Serum Gd-IgA1 and advanced oxidation protein product (AOPP) levels were measured using ELISA assays. Kidney biopsies were evaluated according to the Oxford MEST-C scoring, with C4d and CD68 staining.
RESULTS: Seventeen patients (36%) experienced ESKD during a median follow-up time of 6 years (IQR 3.7-7.5). Serum AOPP levels were correlated with the intensity of glomerular C3 deposition (r = 0.325, p = 0.026), glomerular (r = 0.423, p = 0.003) and interstitial CD68 + cell count (r = 0.298, p = 0.042) and Gd-IgA1 levels (r = 0.289, p = 0.049). Serum Gd-IgA1 levels were correlated with the intensity of C3 deposition (r = 0.447, p = 0.002). eGFR at biopsy (adjusted HR (aHR) 0.979 p = 0.011), and E score (aHR, 8.305, p = 0.001) were associated with progression to ESKD in multivariate analysis. 5-year ESKD-free survival rate was significantly lower in patients with higher E score compared to patients with E score 0 [p = 0.021].
CONCLUSIONS: An increased number of macrophages in the glomerular and tubulointerstitial area may play a role in oxidative stress and complement system activation. Endocapillary hypercellularity is a predictive factor for poor prognosis in IgAN.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  IgA nephropathy; Inflammation; Kidney disease; Macrophages; Oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 34787798     DOI: 10.1007/s40620-021-01196-7

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  60 in total

1.  Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

Authors:  Ali G Gharavi; Zina Moldoveanu; Robert J Wyatt; Catherine V Barker; Susan Y Woodford; Richard P Lifton; Jiri Mestecky; Jan Novak; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

2.  The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy.

Authors:  Yasar Caliskan; Yasemin Ozluk; Dilara Celik; Nida Oztop; Aysun Aksoy; Ayse Serra Ucar; Halil Yazici; Isin Kilicaslan; Mehmet Sukru Sever
Journal:  Kidney Blood Press Res       Date:  2016-02-26       Impact factor: 2.687

Review 3.  Novel biomarkers in glomerular disease.

Authors:  Yasar Caliskan; Krzysztof Kiryluk
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

4.  Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB.

Authors:  Carmen Gómez-Guerrero; Oscar López-Franco; Yusuke Suzuki; Guillermo Sanjuán; Purificación Hernández-Vargas; Julia Blanco; Jesús Egido
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

5.  Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells.

Authors:  H C Chen; J Y Guh; J M Chang; Y H Lai
Journal:  Nephron       Date:  2001-07       Impact factor: 2.847

6.  Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells.

Authors:  Alessandro Amore; Paola Cirina; Giovanni Conti; Paola Brusa; Licia Peruzzi; Rosanna Coppo
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

7.  IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.

Authors:  Jan Novak; Milan Tomana; Karel Matousovic; Rhubell Brown; Stacy Hall; Lea Novak; Bruce A Julian; Robert J Wyatt; Jiri Mestecky
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

8.  Genome-wide association study identifies susceptibility loci for IgA nephropathy.

Authors:  Ali G Gharavi; Krzysztof Kiryluk; Murim Choi; Yifu Li; Ping Hou; Jingyuan Xie; Simone Sanna-Cherchi; Clara J Men; Bruce A Julian; Robert J Wyatt; Jan Novak; John C He; Haiyan Wang; Jicheng Lv; Li Zhu; Weiming Wang; Zhaohui Wang; Kasuhito Yasuno; Murat Gunel; Shrikant Mane; Sheila Umlauf; Irina Tikhonova; Isabel Beerman; Silvana Savoldi; Riccardo Magistroni; Gian Marco Ghiggeri; Monica Bodria; Francesca Lugani; Pietro Ravani; Claudio Ponticelli; Landino Allegri; Giuliano Boscutti; Giovanni Frasca; Alessandro Amore; Licia Peruzzi; Rosanna Coppo; Claudia Izzi; Battista Fabio Viola; Elisabetta Prati; Maurizio Salvadori; Renzo Mignani; Loreto Gesualdo; Francesca Bertinetto; Paola Mesiano; Antonio Amoroso; Francesco Scolari; Nan Chen; Hong Zhang; Richard P Lifton
Journal:  Nat Genet       Date:  2011-03-13       Impact factor: 38.330

9.  Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy.

Authors:  Ivan C Moura; Michelle Arcos-Fajardo; Charlotte Sadaka; Valérie Leroy; Marc Benhamou; Jan Novak; François Vrtovsnik; Elie Haddad; Koteswara R Chintalacharuvu; Renato C Monteiro
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

10.  Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.

Authors:  Krzysztof Kiryluk; Yifu Li; Francesco Scolari; Simone Sanna-Cherchi; Murim Choi; Miguel Verbitsky; David Fasel; Sneh Lata; Sindhuri Prakash; Samantha Shapiro; Clara Fischman; Holly J Snyder; Gerald Appel; Claudia Izzi; Battista Fabio Viola; Nadia Dallera; Lucia Del Vecchio; Cristina Barlassina; Erika Salvi; Francesca Eleonora Bertinetto; Antonio Amoroso; Silvana Savoldi; Marcella Rocchietti; Alessandro Amore; Licia Peruzzi; Rosanna Coppo; Maurizio Salvadori; Pietro Ravani; Riccardo Magistroni; Gian Marco Ghiggeri; Gianluca Caridi; Monica Bodria; Francesca Lugani; Landino Allegri; Marco Delsante; Mariarosa Maiorana; Andrea Magnano; Giovanni Frasca; Emanuela Boer; Giuliano Boscutti; Claudio Ponticelli; Renzo Mignani; Carmelita Marcantoni; Domenico Di Landro; Domenico Santoro; Antonello Pani; Rosaria Polci; Sandro Feriozzi; Silvana Chicca; Marco Galliani; Maddalena Gigante; Loreto Gesualdo; Pasquale Zamboli; Giovanni Giorgio Battaglia; Maurizio Garozzo; Dita Maixnerová; Vladimir Tesar; Frank Eitner; Thomas Rauen; Jürgen Floege; Tibor Kovacs; Judit Nagy; Krzysztof Mucha; Leszek Pączek; Marcin Zaniew; Małgorzata Mizerska-Wasiak; Maria Roszkowska-Blaim; Krzysztof Pawlaczyk; Daniel Gale; Jonathan Barratt; Lise Thibaudin; Francois Berthoux; Guillaume Canaud; Anne Boland; Marie Metzger; Ulf Panzer; Hitoshi Suzuki; Shin Goto; Ichiei Narita; Yasar Caliskan; Jingyuan Xie; Ping Hou; Nan Chen; Hong Zhang; Robert J Wyatt; Jan Novak; Bruce A Julian; John Feehally; Benedicte Stengel; Daniele Cusi; Richard P Lifton; Ali G Gharavi
Journal:  Nat Genet       Date:  2014-10-12       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.